Equilateral Enterprises Intrinsic Value
Equilateral Enterprises intrinsic value. Equilateral Enterprises (EQUILATERA) median intrinsic value is ₹4.54 from 7 valuation models (range ₹3–₹21), vs current price ₹8.44 — -46.2% downside (Trading Above Calculated Value), margin of safety -85.9%. Read Equilateral Enterprises dividend policy for the complete payout history and dividend yield track record.
EQUILATERA Valuation Methods Summary — DCF, Graham Number & P/E
Equilateral Enterprises intrinsic value across 7 models vs current price ₹8.44 — upside/downside and value range per method. For current market price and key ratios, visit Equilateral Enterprises screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹2.53 | ₹2.02 - ₹3.04 | -70.0% | EPS: ₹0.10, Sector P/E: 12x |
| Book Value Method | asset | ₹9.17 | ₹8.25 - ₹10.09 | +8.6% | Book Value/Share: ₹9.17, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹16.88 | ₹15.19 - ₹18.57 | +100.0% | Revenue/Share: ₹45.00, P/S: 0.8x |
| Simple DCF (5Y) | dcf | ₹21.10 | ₹16.88 - ₹25.32 | +150.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹2.53 | ₹2.28 - ₹2.78 | -70.0% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹2.53 | ₹2.28 - ₹2.78 | -70.0% | Revenue Growth: 15.0%, Adj P/E: 8.6x |
| Graham Defensive Method | conservative | ₹4.54 | ₹4.09 - ₹4.99 | -46.2% | EPS: ₹0.10, BVPS: ₹9.17 |
EQUILATERA Intrinsic Value vs Market Price — All Valuation Models
Equilateral Enterprises fair value range ₹3–₹21 vs current market price ₹8.44 across 7 valuation models. Compare with Equilateral Enterprises value estimation to assess whether the stock is under or overvalued.
EQUILATERA Intrinsic Value Analysis — Undervalued or Overvalued?
Equilateral Enterprises median intrinsic value ₹4.54, current price ₹8.44 — Trading Above Calculated Value by 46.2%, margin of safety -85.9%.
What is the intrinsic value of EQUILATERA?
Based on our comprehensive analysis using 7 different valuation methods, the estimated intrinsic value of Equilateral Enterprises (EQUILATERA) is ₹4.54 (median value). With the current market price of ₹8.44, this represents a -46.2% variance from our estimated fair value.
The valuation range spans from ₹2.53 to ₹21.10, indicating ₹2.53 - ₹21.10.
Is EQUILATERA undervalued or overvalued?
Based on our multi-method analysis, Equilateral Enterprises (EQUILATERA) appears to be trading above calculated value by approximately 46.2%.
EQUILATERA Financial Health — Key Ratios vs Industry Benchmarks
Equilateral Enterprises financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | -6.00 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Operating Margin | -4.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 2.35x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
EQUILATERA Cash Flow Quality — Operating & Free Cash Flow
Equilateral Enterprises operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹4 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |
| March 2025 | ₹6 Cr | ₹3 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹6 Cr | ₹6 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹-14 Cr | ₹-14 Cr | Negative Cash Flow | 3/10 |